D. Pariser, J. Sussman, B. Martin, L. Ackerman, C. Kraffert, and A. Jarell, “Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients with Stage I-III Cutaneous Melanoma ”, J of Skin, vol. 8, no. 2, p. s386, Mar. 2024.